Global Hormonal Contraceptive Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Hormonal Contraceptive Market Research Report 2024
Hormonal contraception refers to birth control methods that act on the endocrine system. Almost all methods are composed of steroid hormones.
According to MRAResearch’s new survey, global Hormonal Contraceptive market is projected to reach US$ 21910 million in 2033, increasing from US$ 17480 million in 2022, with the CAGR of 2.8% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hormonal Contraceptive market research.
North America dominated the global hormonal contraceptive market and is expected to retain its position throughout the forecast period. This can be attributed to high per capita income, strong presence of key market players, higher awareness about sexual health, etc.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Hormonal Contraceptive market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Ansell Limited
Bayer AG
Church and Dwight Co
Johnson and Johnson
Mayer Laboratories
Merck and Co
Mylan N.V.
Pfizer
Teva Pharmaceutical Industries
The Female Health Company
Organon International
Afaxys
Segment by Type
Oral Contraceptive Pills
Injectable Birth Control
Emergency Contraceptive Pills
Vaginal Rings
Transdermal Patches
Hospitals
Household
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Hormonal Contraceptive report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Hormonal Contraceptive market is projected to reach US$ 21910 million in 2033, increasing from US$ 17480 million in 2022, with the CAGR of 2.8% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hormonal Contraceptive market research.
North America dominated the global hormonal contraceptive market and is expected to retain its position throughout the forecast period. This can be attributed to high per capita income, strong presence of key market players, higher awareness about sexual health, etc.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Hormonal Contraceptive market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Ansell Limited
Bayer AG
Church and Dwight Co
Johnson and Johnson
Mayer Laboratories
Merck and Co
Mylan N.V.
Pfizer
Teva Pharmaceutical Industries
The Female Health Company
Organon International
Afaxys
Segment by Type
Oral Contraceptive Pills
Injectable Birth Control
Emergency Contraceptive Pills
Vaginal Rings
Transdermal Patches
Segment by Application
Hospitals
Household
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Hormonal Contraceptive report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source